Spotlight and Briefings

Back to feed
Spotlight 7 days 30 days 90 days 365 days

Navigate 7-day Briefings

2026-05-17 - 2026-05-23 ← Older
2026-05-31 - 2026-06-06 Newer →

Ireland unveils Sláintecare 2025+ roadmap and 2026 Waiting List Plan amid HSE briefing revealing systemic staffing and capacity deficits.

7 day briefing • 2026-05-24 - 2026-05-30 (1 week ago) • frozen

Spotlight this

This week in Irish health policy was dominated by the publication of two landmark documents: the Sláintecare 2025+ plan ("The Path to Universal Healthcare") and the 2026 Waiting Time Action Plan. Together, they aim to advance Ireland's decade-long healthcare reform, setting 23 priority actions to reduce waiting lists, expand community care, and boost digital health. However, the impact of these plans is shadowed by internal HSE briefing notes obtained this week, which expose deep-rooted challenges facing new CEO Anne O'Connor: fragile gains in ED overcrowding, persistent mental health staffing deficits, missed BreastCheck targets for three consecutive years, and high nursing emigration intentions. The briefing notes also reveal that a €20m intervention is needed just to reduce therapy waiting lists, while children's dental checks fell 70,000 short. The waiting list itself reached 889,000 by end-2025, and the new action plan sets hospital-specific targets backed by NTPF funding to treat long-waiting patients abroad.

On drug reimbursement, the NCPE recommended against reimbursing belzutifan (Welireg) for von Hippel-Lindau disease unless cost-effectiveness improves, and issued a rapid review recommending a full HTA for zilucoplan in myasthenia gravis. A new government-industry deal commits the HSE to make reimbursement decisions within six months of a positive NCPE recommendation. Meanwhile, HIQA's health technology assessment on the shingles vaccine's effect on dementia risk concluded that current evidence is insufficient to prove causation, though an association exists. The assessment does not change current vaccination policy. COVID-19 spring booster uptake remains concerningly low: only 8.9% of those aged 80+ had been vaccinated by week 17, half the rate of the previous spring campaign, according to HPSC data.

Several observational studies published this week linked GLP-1 receptor agonists (e.g., Ozempic) to reduced metastatic progression in obesity-related cancers, adding to the debate about their broader health benefits. The HSE also launched a new tiered Autism Assessment and Intervention Pathway Protocol, and the seventh National Inpatient Experience Survey began sending invitations to 40 public hospitals. The cumulative picture is of a health system under severe strain, with policymakers racing to implement reforms while tackling day-to-day capacity and workforce crises.

Navigate Timescales

7 days Current

2026-05-24 - 2026-05-30

30 days

2026-04-24 - 2026-05-23

90 days

2026-02-23 - 2026-05-23

365 days

2025-05-24 - 2026-05-23

Each tier targets the nearest available window end date to this briefing.

Pillar Signal Heatmap

Pillar 7d Trend
Health Policy & Regulation
HSE Service Delivery
Medical Breakthroughs & Research
Patient Advocacy & Rights
Pharmaceuticals & Medical Imports
Public Health & Disease Surveillance
Healthcare Workforce & Training
Health Economics & Funding

Intensity is derived from pillar keyword overlap with headline, summary, key signals, and themes for each horizon.

Trend uses last 2 entries in this 7-day timescale (rightmost point is current).

Key Signals

  • - Government publishes Sláintecare 2025+ plan ('The Path to Universal Healthcare') with 23 priority actions focused on waiting lists, community care, and digital health.
  • - 2026 Waiting Time Action Plan sets hospital-specific targets backed by NTPF funding, including treatment abroad for long-waiting patients.
  • - Internal HSE briefing notes reveal systemic challenges for new CEO: missed BreastCheck targets (3 years), high nursing emigration, and ED overcrowding fragility.
  • - NCPE recommends against reimbursing belzutifan (Welireg) for VHL disease unless cost-effectiveness improves; rapid review recommends full HTA for zilucoplan in gMG.
  • - HIQA concludes evidence insufficient to prove shingles vaccine reduces dementia risk, though an association exists; no policy change recommended.
  • - COVID-19 spring booster uptake among 80+ is only 8.9% by week 17, half the 2025 spring campaign rate (20.9% at same point).
  • - Multiple observational studies link GLP-1 receptor agonists to reduced metastatic progression in obesity-related cancers, signaling potential repurposing.
  • - HSE launches tiered Autism Assessment and Intervention Pathway Protocol; seventh National Inpatient Experience Survey begins text invitations.

Top Themes

sláintecare-2025-plus waiting-list-action-plan hse-workforce-crisis drug-reimbursement ncpe-hta vaccine-uptake glp-1-cancer hiqa-regulations autism-assessment inpatient-survey

Key References

  1. Sláintecare 2025+: Minister for Health Publishes Updated Universal Healthcare Plan [deepseek_search]

    Official publication of Sláintecare 2025+ plan, the government's updated universal healthcare roadmap.

  2. HSE briefing documents reveal scale of challenges for new CEO Anne O'Connor [deepseek_search]

    Internal HSE briefing documents outlining systemic challenges for new CEO, including missed targets and staffing deficits.

  3. Minister for Health publishes the Waiting Time Action Plan 2026 [deepseek_search]

    Ministerial publication of the 2026 Waiting Time Action Plan with specific hospital targets and NTPF funding.

  4. NCPE Recommends Against Reimbursement of Belzutifan (Welireg) for von Hippel-Lindau Disease in Ireland [deepseek_search]

    NCPE final HTA recommending against reimbursement of belzutifan for VHL disease, a key reimbursement decision.

  5. NIAC Issues Updated Standing COVID-19 Vaccination Recommendations for Ireland (May 2025) [deepseek_search]

    NIAC updated standing COVID-19 vaccination recommendations and uptake data for the spring 2025 campaign.

  6. COVID-19 Spring Booster Uptake in Ireland: HPSC Reports Low Early Uptake Among Over-80s [deepseek_search]

    HPSC surveillance report showing critically low COVID-19 spring booster uptake (8.9% among 80+).

  7. HIQA: Evidence Insufficient to Recommend Shingles Vaccine for Dementia Prevention [deepseek_search]

    HIQA assessment on shingles vaccine and dementia risk, concluding insufficient evidence for causation.

  8. GLP-1 Receptor Agonists Associated with Reduced Metastatic Progression in Obesity-Related Cancers [deepseek_search]

    Observational study linking GLP-1 RAs to reduced metastatic progression in obesity-related cancers, informing potential clinical implications.